The LDS Church's stock investment arm is buying up stocks again but has seen the portfolio's overall value slip.
On a recent conference call, Axsome Therapeutics reported strong year-over-year growth across its business in the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results